Researchers at the Roswell Park Cancer Institute have developed a method utilizing nanotechnology to control the growth of tumors. The technique that they devised reduced the growth of tumors by up to 45% after just one week. This new technology utilizes radioactive gold composite nanodevices (CNDs) to target the cancer. There were no adverse affects detected in the subjects after the treatment.
Advancements such as this outweigh much of the criticism put upon the field of nanotechnology. If used properly, nanotechnology holds a lot of promise for humanity.
Lead Researchers:
Lajos P. Balogh, PhD, Director of Nanotechnology Research and Mohamed K. Khan, MD, PhD, Associate Director of Translational Research and a physician in the Department of Radiation Medicine at Roswell Park.
Source:
No comments:
Post a Comment